Hatteras Venture Partners related stories
All articles and analysis
Wildflower Health scores $8 mln in HEP-led roundSan Francisco-based Wildflower Health, a mobile health software company, has secured $8 million in funding. Health Enterprise Partners led the round with participation from Hatteras Venture Partners and Echo Health. In addition to the funding, Ezra Mehlman of HEP, has been added to Wildflower Health's board of directors.
- Biotech company Ribometrix snags $7.5 mln seed
Ribometrix Inc, a biotech company focused on developing small molecule modulators of RNA to treat disease, has raised $7.5 million in seed funding. SV Health Investors and Hatteras Venture Partners led the round with participation from AbbVie Ventures, the Dementia Discovery Fund, MP Healthcare Venture Management and Alexandria Venture Investments.
- Rodin Therapeutics seals $27 mln
Cambridge, Massachusetts-based Rodin Therapeutics, a biotech company, has closed $27 million in financing. The investors included Atlas Venture, GV, Hatteras Venture Partners, Remeditex Ventures and Third Point Ventures.
- Biotech company ORIG3N nabs $20 mln
Boston-based ORIG3N, a biotechnology company that is developing treatments for rare and genetically inherited diseases, has raised $20 million in funding. Hatteras Venture Partners led the round with participation from Spectrum Health Ventures, LabCorp, Syno Capital, KTB-KORUS Fund, MGC Venture Partners, DEFTA Partners and 180 Degree Capital. In conjunction with the funding, Byron Smith, a principal at Mountain Group Partners, has been added to ORIG3N's board of directors.
- NeuroTronik inks $23.1 mln
NeuroTronik, a developer of technology that helps doctors treat heart failure patients, raised $23.1 million in Series B preferred stock financing. Boston Scientific Group led the round with participation from other investors that included Hatteras Venture Partners, Synergy Life Science Partners, Lord Baltimore Investment Partners and Mountain Group Capital.
- Bivarus scores $4 mln Series B
North Carolina-based Bivarus, a provider of analytics for healthcare organizations, has raised $4 million in Series B funding. Hatteras Venture Partners led the round with participation from other investors that included Excelerate Health Ventures, NueCura Partners and Boston Millennia Partners.
- Agricultural tech startup Boragen nets $10 mln Series A
Boragen, an agricultural tech startup newly launched from AgTech Accelerator, has raised $10 million in Series A funding. The investors include Alexandria Venture Investments, ARCH Venture Partners, the Bill & Melinda Gates Foundation, Hatteras Venture Partners, Mountain Group Capital, Pappas Capital and Syngenta Ventures.
- Hatteras Venture Partners and Malin back Artizan
Durham, North Carolina-based Artizan Biosciences Inc, a new biotech company, has secured an undisclosed amount of funding. The investors were Malin, which acquired a 32 percent stake in Artizan and Hatteras Venture Partners.